Joe Conner Selected Research

Joe Conner Research Topics

13	Neoplasms (Cancer) 01/2022 - 04/2012
4	Infections 01/2018 - 09/2002
2	Rhabdomyosarcoma 12/2017 - 01/2017
2	Guillain-Barre Syndrome 07/2004 - 09/2002
1	Pleural Effusion (Pleural Effusions) 01/2022
1	Malignant Mesothelioma 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 07/2021
1	Mesothelioma 12/2020
1	Viremia 11/2019
1	Inflammation (Inflammations) 01/2018
1	Diffuse Intrinsic Pontine Glioma 06/2017
1	Brain Neoplasms (Brain Tumor) 06/2017
1	Glioma (Gliomas) 06/2017
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 06/2017
1	Neurofibrosarcoma (MPNST) 03/2017
1	Neuroblastoma 03/2017
1	Herpes Simplex 01/2017
1	Enteritis 07/2004

3	CytokinesIBA 01/2022 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 07/2021 - 08/2003
2	LipopolysaccharidesIBA 07/2004 - 09/2002
2	GangliosidesIBA 07/2004 - 09/2002
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 07/2021
1	Immunoglobulin G (IgG)IBA 12/2020
1	HMGB1 Protein (HMG1)IBA 01/2018
1	Transforming Growth Factor-beta Type I ReceptorIBA 12/2017
1	Glycogen Synthase (Synthase I)IBA 06/2017
1	dipinacoline glutamateIBA 06/2017
1	Aurora Kinase AIBA 03/2017
1	MLN 8237IBA 03/2017
1	Apoptosis Regulatory ProteinsIBA 01/2017
1	LigandsIBA 01/2017
1	Radioisotopes (Radionuclides)IBA 04/2012
1	N-acetyltalosaminuronic acid (NAT)IBA 04/2012
1	simplexvirus receptorIBA 08/2005
1	AntibodiesIBA 07/2004
1	DNA (Deoxyribonucleic Acid)IBA 08/2003
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2003
1	OligosaccharidesIBA 09/2002
1	AutoantibodiesIBA 09/2002

7	Therapeutics 01/2022 - 04/2012
5	Oncolytic Virotherapy 01/2022 - 01/2017
3	Immunotherapy 01/2022 - 12/2017
2	Intravenous Injections 11/2019 - 04/2012
1	Intravenous Administration 01/2021
1	Drug Therapy (Chemotherapy) 01/2013
1	Drug Tapering 01/2013
1	Radiotherapy 04/2012